{"title": "PDF", "author": "PDF", "url": "https://www.uab.edu/medicine/icos/images/POCC_Report/Bi-weekly_POCC_Report/Vaccine.10.20.2021.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "Age: Median (Range) 17.5y (0-39) N % Gender Female 19 41% Race / Ethnicity Non -Hispanic White 24 57% Hispanic or Latino 8 20% Black 7 17% Insurance Public/Uninsured 17 37% Private 25 54% Vaccination Location Oncology Office 14 30% *To report cases, find the POCC report, a copy this report and FAQs, visit: https://www.uab.edu/medicine/icos/icos -research/the -pocc -report Allergic Reaction History History of Allergic Reaction 12 29% To Previous Vaccines 1 2% To Pegylated Asparaginase 2 4% ToEtoposide 0 0% Other 10 22%Days between Chemotherapy & Vaccine : Median: 53 days (30 -350)Local/Systemic Reactions: Chills, Fatigue, Fever, Headache, Injection Site Pain, Nausea, Vomiting Previous COVID Infection: 5 (11%)Patients, Vaccines & Reactogenicity Dose "}